Seizures, benign familial neonatal, 1
MONDO:0007365Any benign neonatal seizures in which the cause of the disease is a mutation in the KCNQ2 gene.
Also known as: myokymia, KCNQ2 benign neonatal seizures, benign neonatal seizures caused by mutation in KCNQ2, seizures, benign familial neonatal, 1, seizures, benign familial neonatal, type 1, seizures, benign neonatal, 1, BFNS1, epilepsy, benign neonatal, 1, and/or myokymia
7 clinical trials for this condition and its sub-types, 0 tagged with Seizures, benign familial neonatal, 1 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Real-World study tracks Epidyolex's Long-Term impact on seizures
Disease control OngoingThis study follows 158 people in France who are prescribed Epidyolex (a cannabidiol-based medicine) for seizures as part of their normal care. Researchers will track how long people stay on the treatment, side effects, seizure frequency, and changes in daily functioning and quali…
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New inhaler aims to stop prolonged seizures fast and safely
Symptom relief By invitation onlyThis study tests the long-term safety of an inhaled medication called Staccato alprazolam for people aged 12 and older who have prolonged seizures. About 300 participants will use the inhaler when a seizure starts to see if it stops the seizure quickly and without serious side ef…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC